Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Arthritis | D001168 | HP_0001369 | M05-M14 | 1 | 4 | — | — | — | 5 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 1 | 2 | — | — | — | 3 |
Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | — | 2 | — | — | — | 2 |
Drug common name | REMTOLUMAB |
INN | remtolumab |
Description | Remtolumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against tumor necrosis factor and interleukin-17A. |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4297863 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 1V8WRH3RVX (ChemIDplus, GSRS) |